throbber
Available online at www.sciencedirect.com
`
`SCIENCE@DIAECT•
`
`ELSEVIER
`
`European Journal of Pharmaceutical Sciences 21 (2004) 471--477
`
`IUJIOPIAN JOUllNAL OP
`
`PHAR~IACEUTl~AL
`SCIENCES
`
`www .e lsev ier .com/locate/ej ps
`
`In vitro permeation of several drugs through the human nail plat1e .. : ~---,
`l.al)e
`relationship between physicochemical properties and nail
`EXHIBIT NO. 5
`permeability of drugs
`Yoichi Kobayashi a, Tsunehisa Komatsu•, Machiko Sumi a, Sachihiko Numajiri a-..•k•--~lili.J
`Misao Miyamotob, Daisuke Kobayashi a, Kenji Sugibayashia, Yasunori Morimoto•·'
`
`" Facuf(v i?{Pharmaceulical Sciences, Josai University, J-1 Keyakidai, Sakado, Saitama 350-0295. Japan
`b Nissan Chemical Co., ltd, 3-7-1 Ka11da-Nishiki-cho. Chiyoda-ku, Tokyu 101-0054, Japan
`
`Received I 0 April 2003: received in revised fonn ! 0 October 2003; accepted 17 November 2003
`
`Abstract
`
`The objectives of the present study arc to clarify the relationship between the physicochc1nical properties and the nail penncability of drugs
`through human nail plates. Ho1nologous p-hydroxybenzoic acid esters were used to investigate the relationship between the octanol/watcr
`partition coetficient and the penneability coeflicient of several drugs. The nail permeability was fOund to be independent of the lipophilicity
`of a penetrating drug. However, the nail pcnneabi\ity of several 1nodcl drugs was found to 1narkedly decrease as their 1nolecular weights
`increased. The nail permeability of an ionic drug was found to be significantly lower than that of a non-ionic drug, and the nail penneability of
`these drugs markedly decreased as their molecular \veights increased. The permeation ofa model drug, 5-0uorouracil (5-FU), through healthy
`nail plates was also dctcnnincd and coinparcd with that through nail plates with fungal infections. The drug permeation through a nail plate
`pecrcas_t;_Q _with an incr~?SC i.1.1. n~il_ pl_~tc thick1_1i;:S;5._Nail pl~t.es_with fl~pgµl iQfections .e~.J:tjbited approximately the S<!-lne 5-FU pcnneation as
`hcUlthy. iiU.ii" plates. We suggest thai the penneability of a drug is 1nalnly influencl!d by its molecular weight and penneability through nails
`with fungal infection can be esti1nated from data on healthy nail pcnneability.
`© 2004 Elsevier B.V. A!\ rights reserved.
`
`Klywords: Nail; Nail permeation; Fungal nail phttc; Onychomycosis; Antifungal agents
`
`1. Introduction
`
`Onychomycosis has been treated 111ainly with oral anti(cid:173)
`fungal medication (Piepponen et al., 1992; Vi liars and Jones,
`1992). This oral therapy, however, sometin1es has severe
`systemic side effects, which interrupt treatment (Wilson and
`Plunkett, 1962). On the other hand, it is well known that
`topical treatment is not \\l·idely used in onychon1ycosis ther(cid:173)
`apy. The anticipated low levels of nail penetration and per(cid:173)
`meation during topical antifungal drug exposure are very
`significant factors in onychotnycosis therapy. Only a few
`drug penneation studies have been performed on the hun1an
`·nail plate and, as a consequence, the mechanisn1s behind
`healthy and fungal nail permeation have yet to be confirmed.
`Walters et al. ( 1983) have suggested that the nail plate be-
`
`~ Concsponding author. Tel.: +81-49-271-7685;
`fax: +81-49-285-5863.
`E-mail address: morimoto((_&josai.ar:.jp (Y. Morimoto).
`
`0928-0987/$ - sec front matter~) 2004 Elsevier I3.V. All rights reserved.
`doi: 10. ! 016/j.cjps.2003.11.008
`
`haves like a hydrophilic gel membrane and that there is an
`additional lipophilic route, as revealed by an in vitro pen(cid:173)
`etration study of homologous alcohols through the human
`nail plate. Mertin and Lippold ( 1997) also suggested that
`the nail plate behaves like a hydrophilic gel 1ne111brane and
`that the dissociation of a penetrating drug leads to a re(cid:173)
`duction in the penetration rate, as revealed by an in vitro
`penetration study of homologous nicotinic acid esters, ben(cid:173)
`zoic acid and pyridine through the hu1nan nail plate and
`bovine hoof membrane. Since they used healthy nails fron1
`dead men and women for the in vitro pern1eation study, they
`were probably not able to cany out n1any permeation stud(cid:173)
`ies using human nail plates. We have developed a modified
`side-by-side diffusion cell using nail tip pieces fro1n healthy
`volunteers in order to investigate the nail penetration niech(cid:173)
`anisn1 and enhancing systen1. Fron1 the results we obtained
`using our in vitro technique, we suggest that dn1g diffu(cid:173)
`sion in the upper layer of the hun1an nail plate is the niain
`barrier to nail permeation and that the full-thickness nail
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 1 of 8
`
`

`
`472
`
`Y. Kobaya,;hi el al. I European Journal of Pharmace11/ical Science:; 2 J (2004) 471-477
`
`plate behaves like a hydrophilic gel membrane (Kobayashi
`et al., 1999). In addition, we found that N-acetyl-t-cysteine
`and 2-mercaptoethanol are able to enhance drug permeation
`through the human nail plate (Kobayashi et al., 1998). How(cid:173)
`ever, it is very difficult to evaluate antifungal drug perme(cid:173)
`ation, because of the ve1y low nail pern1eability involved.
`In order to clarify the nail permeation mechanism of drugs
`through human nail plate, we studied the relationship be(cid:173)
`tween the physicochemical properties and the healthy nail
`pern1eability of several drugs. To observe the effect of oc(cid:173)
`tanol/water partition coefficients on nail Permeability coeffi(cid:173)
`cients, homologous p-hydroxybenzoic acid esters were used
`as model drugs. The effects of the molecular weight and drug
`dissociation on nail permeability were also investigated in a
`nail permeation study using several model drugs. We inves(cid:173)
`tigated the relationship between the flux of a model drug,
`5-ftuorouracil (5-FU), and the healthy or fungal nail plate
`thickness.
`
`nail plates were used to make a co1nparison between the
`different drug permeabilities. After healthy and fungal nail
`pieces were hydrated for a day, they were used to evaluate
`drug permeability.
`
`2.3. Determination oj'solubilities and octanol!water
`partition coefficients
`
`The drug suspensions \Vere mixed with a magnetic stin·er
`at 37°C. After 12 and 24h, each suspension was subjected
`to filtration (Ekicrodisc 3; German Sciences Japan, Ltd.,
`Tokyo). The filtrate was immediately diluted with methanol
`or acctonitrile to obtain samples for analysis. No difference
`in drug solubility was observed between 12 and 24h. The
`octanol/water partition coefficient of the drugs (K0 w) was
`defined as the solubility ratio in octanol/water at 37"C. A
`few of the values were taken from the literature (Morimoto
`et al., 1992).
`
`2. Experimental
`
`2. 1. Materials
`
`Antipyrine, 5-FU, p-hydroxybenzoic acid esters (methyl
`ester, MP; ethyl ester, EP; propyl ester, PP; butyl ester,
`BP; amyl ester, AP; hexyl ester, HP) and sodium nicotinate
`were obtained from Tokyo Kasei Kogyo Co. (Tokyo, Japan).
`Aminopyrine, barbital sodium, benzoic acid, ethanol, pro(cid:173)
`caine hydrochloride, pyridine and sodium benzoate were ob(cid:173)
`tained fro.m Wako Pure Chemical Industries (Osaka, Japan).
`Deuterium oxide was obtained fro1n Merck Co. (Darmstadt,
`Gem1any). lsoproterenol hydrochloride, lidocaine, lidocaine
`hydrochloride and mexiletin hydrochloride-were obtained
`from Sigma Chemical Co. (St. Louis, MO, USA). Crocona(cid:173)
`zole hydrochloride was supplied by Shionogi & Co. (Osaka,
`Japan). Isosorbide dinitrate was supplied by Toko Pharma(cid:173)
`ceutical Ind. Co. (Tokyo). All other reagents were obtained
`fron1 commercial sources.
`
`2.2. Preparation of the nail plate
`
`I-lealthy nail tip pieces were obtained from the fingers and
`toes of healthy volunteers (15 1nales and 5 fen1ales; 1nean
`age 25 years, range 20-45) using nail clippers. Nail pieces,
`which had been allowed to grow for at least one month,
`were used in this permeation study. Fungal nail plates
`were supplied from Saiseikai Central Hospital (Tokyo) and
`Saitama Medical Center (Saitama Medical School, Saitama,
`Japan). The thickness of the healthy and fungal nail pieces
`was measured with a rnicron1eter (Mitutoyo Corp., Japan)
`equipped with pointed metal attachn1ents. l-Iealthy nail
`plates, having a thickness of about 400 µm (350--450 µm),
`were used to evaluate the effect of the octanol/water par(cid:173)
`tition coefficient, molecular weight and dissociation of the
`penetrant on the nail permeability. Both fungal and healthy
`
`2.4. Permeation studies
`
`A piece of nail plate was sandwiched between two
`adapters n1ade of polypropylene with an 0-shaped ring
`(effective diffusion area 0.049 cm2) and mounted in a
`side-by-side diffusion cell ( 1.5-2.5 ml) with a water jacket
`connected to a water bath at 37°C (Kobayashi et al., 1998).
`The dorsal nail plate side was filled with a drug suspension
`or solution (almost all dn1gs were applied as suspensions,
`but for drugs with a high solubility, the dorsal nail plate side
`was filled with drug solution. The maximun1 flux was eval(cid:173)
`uated frotn the {lux obtained with the applied concentration
`and drug solubility. In both cases, the drug concentration in
`the dorsal nail plate side was almost constant throughout the
`nail permeation studies) and the ventral nail plate side was
`filled with distilled water. No preservative was added be(cid:173)
`cause the receiver solution was clear even at the end of the
`experin1ent. Drug permeation was n1easured by sampling
`the solution on the ventral nail plate side at pre-determined
`tin1es. The experimental period was 5-17 days, because of
`the low degree of nail permeability of the drngs used.
`
`2. 5. Analytical 1nethods
`
`Deuterium oxide was quantified from the intensity of
`·the 0-D stretching vibrational band at 2512 cm- 1 with
`an infrared spectrophotometer (260-30, Hitachi, Tokyo)
`(Ilatanaka et al., 1993). Ethanol was measured by GC
`as described previously (Kobayashi et al., 1997). Other
`dn1gs were determined by l·IPLC. Sample solutions were
`injected
`into an l-IPLC consisting of a pump system
`(LC-IOA, Shimadzu Seisakusho, Kyoto, Japan), an UV
`detector (SPD-IOA, Shimadzu), a chromatopack (C-R5A,
`Shimadzu), a system controller (SCL-IOA, Shimadzu), an
`auto injector (SIL-JOA, Shi1nadzu), and a reverse-phase
`column (lnertsil ODS 250 mm x 4.6 mm i.d., GL Sci(cid:173)
`ences Inc., Tokyo). The 1nobile phase, which consisted
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 2 of 8
`
`

`
`Y. Kobayashi et al. I European Journal of Pharmace11tical Sciences 21 (2004) 471-477
`
`473
`
`of methanol/0.1 o/o phosphoric acid or acetonitrile/0.1 %
`phosphoric acid mixtures, with or without ion-pair chro(cid:173)
`matography reagents (sodiutn l-hexanesulfonate or sodiun1
`dodecylsulfate), was pumped at ~ow rate ranging from I to
`1.5 ml/min. No other peak apatt from the drug and inter(cid:173)
`nal standard was observed on the J-IPLC recording. It was
`clear that the pern1eating dn1gs were stable and no n1aterial
`leached from the nail plates during the permeation studies.
`
`3. Results and discussion
`
`3.1. Influence o.f the octano/!1vater partition coefficient on
`the permeability coefficient
`
`The steady-state permeation of drugs
`the
`through
`solution-diffusion membrane is characterized by Fick's law:
`
`l=
`
`DmKmCv
`h
`
`(!)
`
`in which J is the steady-state flux, Km is the membrane/donor
`vehicle partition coefficient of the drug, Dm is the diffusion
`coefficient of the drug in the 1nembrane, Cv is the concen(cid:173)
`tration in the donor solvent and h is the men1brane thick(cid:173)
`ness. The permeability coefficient (P) can be characterized
`as follows:
`
`P= DmKm.
`
`"
`
`(2)
`
`To predict the skin.permeability of drugs, Potts and Guy
`( 1992) carried out their analysis using a mathen1atical 1nodel
`based on pern1eant size (molecular volun1e (MV) or molec(cid:173)
`ular weight (MW)) and octanol/water pa1tition coefficient
`(K0 w ). The functional dependence of Dm on MW is expo(cid:173)
`nential and it can be characterized by:
`
`Dm = D 0 exp(-,8 MW)
`
`(3)
`
`900
`
`Cu1nulative amount
`
`800
`i 700
`-2r, 600
`2
`"' 500 M
`§ 400
`" JOO
`~ ;; 200
`100
`
`~
`
`0
`
`0
`
`where D0 represents the diffusivity of a hypothetical
`molecule having zero molecular weight and fi is a constant.
`The relationship between Km and Kow is better expressed as:
`
`Km = [Kow]/
`
`(4)
`
`where the coefficient,/, accounts for the difference between
`the partitioning domain presented by octanol and that pre(cid:173)
`sented by the membrane lipids. A combination of Eqs. (2),
`(3) and (4) yields Eq. (5):
`log P = Jog(D0 / h) +flog Kow -
`
`fl' MW
`
`(5)
`
`where ,B' = ,B/2.303,
`The effect of the octanol/water partition coefficient on
`the permeability coefficient of each drug was investigated.
`Fig. I shows a typical permeation profile of one of the
`model drugs, p-hydroxybenzoic acid n1ethyl ester, through
`the healthy human nail plate. Steady-state fluxes of homol(cid:173)
`ogous p-hydroxybenzoic acid esters can be observed from
`4.5 to 6.5 days allowing calculation of the nail permeability
`coefficients.
`Table I shows the physicochen1ical paran1eters and nail
`permeability coefficients of homologous p-hydroxybenzoic
`acid esters used as model drugs in this investigation. The
`molecular weights of homologous p-hydroxybenzoic acid
`esters covered a narrow range from 152.12 to 222.28. The
`logarithm values of the octanol/water partition coefficients
`varied widely from 1.53 to 4.25.
`Fig. 2 shows the relationship between the octanol/water
`partition coefficient and
`the penneability coefficient
`of p-hydroxybenzoic acid esters. The pern1eability of
`p-h}idroXybenzoic acid est6rs did not increa-se with an in(cid:173)
`crease in lipophilicity. If a nail plate behaves as a lipid par(cid:173)
`tition membrane, the slope([) should be clearly greater than
`O; but it was nearly zero (f = -0.160). Multiple regres(cid:173)
`sion analysis was carried out to clarify which paran1eters
`(molecular weight or octanol/water partition coefficient)
`contribute to the permeability of p-hydroxybenzoic acid
`
`Flux
`
`180
`
`150
`
`':;:;
`0
`
`120
`
`" E
`u "' 90
`2 ,
`0 c
`~ ::;
`
`60
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`Time (day)
`
`•
`
`30
`
`0
`
`0
`
`2
`
`3
`
`4
`
`6
`
`7
`
`Time (<lay)
`
`Fig. \. Typical permeation profile of p-hy<lroxybenzoic acid methyl ester:; through the healthy human nail plate. Each value represents the mean± S.E.
`(!! =4).
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 3 of 8
`
`

`
`474
`
`Y. Kobayashi et al. I European Journal of Pharmace11/ical Sciences 21 (2004) 471-477
`
`Table I
`Physicochcmical parameters and nail permeability coefficients (h
`400 µm) of p-hydroxybcnzoic acid esters
`
`Drug
`
`MW
`
`logKowa
`
`pb
`
`in the human nail plate has been found to be 1nuch lower than
`in the stratum corneum of skin (Walters and Flynn, 1983).
`Thus, there does not appear to be an additional Iipophilic
`route in the hun1an nail plate.
`
`152.15
`
`1.53
`
`166.18
`
`2.23
`
`180.20
`
`2.75
`
`194.23
`
`3.13
`
`p-Hydroxybenzoic acid
`methyl ester (MP)
`p-Hydroxybcnzoic acid
`ethyl ester (EP)
`p-Hydroxybenzoic acid
`propyl ester (PP)
`p-Hydroxybenzoic acid
`butyl ester (BP)
`p-Hydroxybcnzoic acid
`amyl ester (AP)
`p-Hydroxybcnzoic acid
`hcxyl ester (HP)
`Each value represents mean ± S.E. (11 = 4).
`" K0w: octanol/watcr partition coefficient.
`b P: permeability cocllicicnt (x 107 cm/s).
`
`208.25
`
`3.65
`
`222.28
`
`4.25
`
`3.68 ± 0.08
`
`2.43 ± 0.48
`
`2.01 ± 0.35
`
`2.38 ± 0.32
`
`2.24 ± 0.39
`
`1.24 ± 0.32
`
`3.2. Influence of the molecular lveight and dissociation on
`the permeability coefficient
`
`Nail permeability was found to be independent of the
`lipophilicity of the drug used. From the findings in this early
`study, the coefficient,}; in Eq. (5) can be assumed to equal
`zero. Thus, substitution of .f = 0 in Eq. (5) gives a sin1ple
`1nodel as follows:
`
`log P =log ( ~0)- fl' MW.
`
`(6)
`
`We investigated the nail permeability of several model
`drugs having various molecular weights. Because the influ(cid:173)
`ence of drug dissociation on the nail permeability is not
`clearly understood, the nail pern1eability of non-ionic and
`ionic drugs was evaluated separately.
`Table 2 su1nn1arizes the pKa, pl-I of the donor solution,
`n1olecular weight and penneability coefficient of the model
`drugs used in this investigation. All the model drugs were
`in the non-ionic form in the donor solution. The 1nolecular
`weight of the model drugs ranged from 20 to 240. The nail
`penneability of drugs having a molecular weight of above
`240 could not be determined, because of the low nail perme(cid:173)
`ability. The nail penneation data of p-hydroxybenzoic acid
`esters (pK, = 8.4, donor pl-I = 3.8-5.8) were added to
`this investigation because they exist in non-ionic forn1 in the
`donor solution.
`-
`According to Eq. (6), Fig. 3 shows the relationship
`between the pern1eability coefficient and the niolecular
`weight of each non-ionic drug. The logarithm of the nail
`penneability coefficient decreased as the molecular weight
`of the penetrating drug increased. A linear relationship
`(r = -0.860, P < 0.01) existed between the permeability
`coefficient and the molecular weight of the model drug,
`the slope (fl') and the intercept (log(D0!h)) being 0.00856
`
`Table 2
`Physicochcmical parameters and nail permeability coefficients (h
`400 µm) of non-ionic model drngs
`
`Drug
`
`pK"
`
`Deuterium oxide
`Ethanol
`Pyridine
`£3cnzoic acid
`5 -Fl uorourncil
`Antipyrine
`Aminopyrine
`Lidocaine
`lsosorbide dinitrate
`
`5.19
`4.19
`8.0, 13.0
`1.50
`5.00
`7.92
`
`rH"
`
`7.81
`7.43
`7.35
`3.21
`4.65
`6.37
`8.44
`10.21
`5.72
`
`MW
`
`20.0
`46.l
`79.1
`122.I
`130.1
`188.2
`232.3
`234.3
`236.1
`
`b
`Pnon
`
`45.52 ± 4.30
`19.81 ± 2.21
`6.36 ± 0.40
`12.84 ± 0.05
`2.08 ± 0.13
`0.53 ± 0.07
`0.09 ± 0.02
`0.39 ± 0.14
`1.5 l ± 0.29
`
`Each value represents mean± S.E. (5-FU, 11 == 30; other drugs, 11 == 3-4).
`" The pH in the donor solution.
`b /',w 11 : perme<1bility coefficient (x 107 cm/s) of non-ionic drugs.
`
`esters. It was suggested that the molecular weight makes
`a greater contribution to the permeability coefficient than
`the octanol/water partition coefficient. The F-values of the
`molecular weight or octanol/water partition coefficient were
`1.9399 or 0.1058, respectively.
`From our findings, it was evident that nail plates behave
`as a hydrophilic gel rne1nbrane rather than a lipophilic parti(cid:173)
`tion membrane. Although this suggestion agreed with the in(cid:173)
`vestigations of Walters et al. (1983) and Mertin and Lippold
`( 1997), an additional lipophilic route suggested by Walters
`et al. ( 1985) could not be found in the human nail plate. It
`has been reported that lipids are present in the dorsal and
`ventral plates, but only at very low levels in the intermediate
`plate which forms the main nail body (Jarrett and Spearn1an,
`1966; Kobayashi et al., 1999). In addition, the lipid content
`
`-4
`
`-5
`
`'.:? -6
`1
`'" ..5 -7
`
`0..
`
`-8
`
`2
`
`3
`Log Kow
`
`4
`
`5
`
`Fig. 2. Relationship between the permeability coefficient (P) and the
`octmtoJ/water partition coefficient (K,)w) of p-hydroxybcnzoic acid esters.
`Each value represents the mcan±S.E. (11 == 4). The abbreviations attached
`lO the closed circle (e) represent the model d1ugs in Table l.
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 4 of 8
`
`

`
`Y. Kobayashi et al. I European Journal of Phannar..:eutical Sciences 21 (2004) 471-477
`
`475
`
`-4
`
`-5
`
`-6
`
`':;;' " -7
`
`3-
`0.
`"' -8
`
`0
`..l
`
`-9
`
`-10
`
`-II
`()
`
`100
`
`200
`M.W.
`
`300
`
`400
`
`Fig. 3. Relationship between the permeability coefficient (P) and the
`molecular weight (MW) of non-ionic and ionic dn1gs. Each value repre(cid:173)
`sents the mean± S.E. (5-FU, n = 30; other drugs, 11 = 3-6). The dotted
`line represents the 95'Yo confidence interval of the regression line. The
`closed circle C•) represents the non-ionic drugs in Table 2. The open
`squurc (0) represents the ionic drugs in Table 3.
`
`and -5.260, respectively. This finding suggests that nail
`permeability depends on the molecular weight of the pen(cid:173)
`etrating dn1g, i.e. the drug diffusivity in the nail plate. The
`nail permeability of non-ionic drugs (P11011 ) can be pre(cid:173)
`dicted approxin1ately fron1 the linear regression (log ? 11011 =
`. -0 .. 00856 MW -,- 5 .260) and molecular weight of each .
`drug.
`Table 3 summarizes the pKa, pI-1 of the donor solution,
`molecular weight and pern1eability coefficient of the other
`model drugs. The model drugs existed in ionic form in the
`donor solution. The molecular weights of the ionic drugs
`used in this investigation ranged from 120 to 312.
`Fig. 3 shows the relationship between the permeability
`coefficient and the molecular weight of the ionic drug. The
`logarithm of the nail penneability coefficient decreased as
`
`Table 3
`Pbysicochemical parameters and nail permeability
`400 µm) of ionic model drugs
`
`coefficients (h
`
`Drug
`
`pKa
`
`pH a
`
`MWh
`
`l'illnc
`
`Sodium bcnzoate
`4.19
`8.12
`4.85
`7.21
`Sodium nicotinate
`7.91
`10.29
`Barbital sodium
`Mexiletin hydrochloride
`9.0
`4.87
`lsoproterenol hydrochloride
`8.57
`4.06
`Li<locaine hydrochloride
`7.86
`4.33
`Procaine hydrochloride
`8.8
`5.27
`Crocon<izole hydrochloride
`6.0
`1.96
`Each value represents mean ± S.E. (11 = 4-6).
`" The pH in the donor solution.
`b The molecular weight with an ionic t01111 of the drug.
`.c 1\m: pcnneability coctncient ( x 107 cm/s) of ionic drugs.
`
`121.1
`122.1
`183.2
`179.3
`211.2
`235.3
`237.3
`3 11.8
`
`0.910 ± 0.136
`0.606 ± 0.204
`0.135 ± 0.016
`0.202 ± 0.057
`0.084 ± 0.013
`0.031 ± 0.003
`0.110 ± 0.016
`0.017 ± 0.009
`
`the molecular weight of the penetrating ionic drug increased.
`A linear relationship (r = -0.966, P < 0.01) also existed
`between the permeability and the molecular weight of the
`ionic drug; the slope (fJ') and intercept (log(D0!h)) were
`0.01030 and -5.907, respectively. The nail permeability of
`ionic drugs (Pion) can also be predicted from the linear re(cid:173)
`gression (log P; 0 , = -0.0!030MW - 5.907) and molecular
`weight of the ionic form. Multiple regression analysis was
`carried out to clarify which para1neters (molecular weight
`or degree of dissociation) contribute to the permeability of
`model drugs. The degree of dissociation of the model dn1gs
`was calculated fron1 the pKa and pl-I in the donor solution.
`It was found that the molecular weight 111akes a greater con(cid:173)
`tribution to the permeability coefficient of model drugs than
`the degree of dissociation. The F-values of the 1nolecular
`weight or degree of dissociation were 10.9254 or 0.8599,
`respectively.
`The permeability coefficient (12.84 x 10- 7 cm/s) of the
`non-ionic form of benzoic acid, which is an acidic drug, was
`about I 0 times higher than that (0.91 x 10-7 cm/s) of its
`ionic form. The permeability coefficient (39 .31 x 1 o-9 c1n/s)
`of the non-ionic form of lidocaine, which is a basic dn1g,
`was also about IO times higher than that (3.10 x 10-9 cm/s)
`of its ionic fonn. In addition, the regression lines, which
`show the relationship between the permeability coefficient
`and the molecular weight of the non-ionic and ionic drugs,
`were parallel to each other. Furthern1ore, the regression line
`of the non-ionic form was about I 0 times higher in position
`than that of the ionic forn1, as shown in Fig. 3. These results
`make it clear that dissociation leads to a reduction in nail
`permeability,· irrespective of the charge on the dn1g. It is·
`thought that the decrease in the pe1n1eability of ionic drugs
`is caused by a small increase (about 100) in the apparent
`molecular weight due to ion hydration.
`In the investigation of Walters et al. ( 1983), they con(cid:173)
`cluded that there was little or no dependence of htunan nail
`permeability on the dissociation of miconazole. However,
`Mertin and Lippold (I 997) contradicted this conclusion be(cid:173)
`cause they found that the dissociation of benzoic acid and
`pyridine leads to a reduction in their penetration rate through
`bovine hoof membrane. They concluded that the decreased
`permeation caused by dissociation, is due to the Donnan
`effect or electrostatic repulsion between the keratin nlem(cid:173)
`brane and the diffusing niolecule. The conclusions that we
`drew from our investigation using hun1an nail plate agree
`with those of the latter researchers. The forn1er researchers
`used citrate/phosphate buffer solution to evaluate the ef(cid:173)
`fect of rniconazole dissociation on nail penneability. Their
`buffer solution has a high ionic strength and is composed of
`compounds exhibiting different ionic fo1n1s (mono-, di- and
`tri-ionic forms) with changing pl-I, co1npared with that (con(cid:173)
`stant ionic strength, /t = 0.158) used in the investigation
`of the latter group. The diffusion coefficient of the tri-ionic
`forms for citrate or phosphate is lower than that of the di-,
`mono-, and non-ionic forms (Southard et al., 1991 ). It seems
`that the decrease in pern1eability due to dissociation could
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 5 of 8
`
`

`
`476
`
`Y. Kobayashi et al. I European Journal of Phw·mace111ical Sciences 21 (2004) 471-477
`
`Table 4
`5-FU flux (J) through fungal nail plates from eight patients
`
`Patient number
`
`Age/gender
`
`I
`2
`3
`4
`5
`6
`7
`8
`
`52/fcmulc
`
`38/male
`42/fcmalc
`
`48/male
`30/male
`
`a h: nail thickness (µm).
`b J: flux (µ.g/cm 2/h).
`
`N'
`
`502
`570
`626
`665
`820
`930
`955
`I !58
`
`.fa
`
`6.25
`13.07
`15.4 l
`9.67
`5.93
`4.26
`3.2J
`0.51
`
`plate thickness. A linear relationship (r = 0.796, slope =
`0.642 µ,g/cm/h, intercept= -3.38 µ,g/cm 2/h, P < 0.01) ex(cid:173)
`isted between the 5-FU flux(.!) through the healthy nail plate
`and the reciprocal of the nail plate thickness (l/h) according
`to Eq. (1) (Fig. 4). In thick nail plates (800-1200µ,m), the
`5-FU flux through fungal nail plates was very similar to that
`through healthy nail plates. However, the 5-FU flux through
`thin fungal nail plates (50()-700 µ,m) tended to be a little
`higher than that through healthy nail plates. No significant
`difference (P = 0.05, Fisher's pairing !-test) was observed
`between the permeability-thickness products (P x h) of
`the healthy and fungal nail plates, calculated using Eq. (2).
`The mean thickness of the fungal nail plates used in this
`study was a little thicker than that of the healthy nail plates
`used. A fungal nail plate, particularly the deepest layer
`in the nail plate (ventral nail plate), generally becomes
`thicker than a"healthy nail plate (Sagher, 1948; Jillson and
`Piper, t 957). The 5-FU flux through the fungal nail plate
`can be estimated from a change in nail plate thickness in
`Fig. 5.
`
`JO
`
`D
`
`not be confirmed due to the interaction of various ions in
`the buffer solution. We did not use a buffer solution because
`it would have complicated the assessment of dn1g diffusiv(cid:173)
`ity in the nail plate. The diffusivity of rv-dicarboxylic acids
`decreased about 5% following complete ionization (Albery
`et al., 1967). In a comparison of the diffusivity of zwitteri(cid:173)
`onic glycine and neutral glycolamide, which have the sa~e
`n1olecular forn1ula, the diffusivity of the ionic compound is
`nearly I Oo/o less than that of the neutral con1pound (Flynn
`et al., 1974). We suggest that the decrease in permeability
`is caused by a decrease in diffusivity due to ion hydration
`rather than the Donnan effect or electrostatic repulsion be(cid:173)
`tween nail keratin and the penetrating drug.
`
`3.3. Comparison between healthy and fungal nail plate
`permeation of the drugs used
`
`Nail plates have different thicknesses in the fingers and
`toes of the hun1an body. To evaluate drug permeation through
`healthy and fungal nail plates, 5-FU was selected as a model
`drug. 5-FU was used because nail permeation can easily be
`detennined and because it is comparatively soluble in water
`( 17. l mg/ml). In this permeation study, 5-FU was suspended
`in all the donor vehicles.
`Fig. 4 shows the relationship between the 5-FU flux and
`the healthy nail plate thickness. 5-FU penetrates healthy nail
`plates of thickness ranging from 225 to 1050 µ,m at a flux
`of 1-28 µ,g/cm 2/h. The 5-FU flux increased as the nail plate
`thickness decreased.
`The 5-FU permeation through fungal nail plates from
`eight patients was investigated (Table 4) antl compared
`with that through nail plates from healthy volunteers. The
`5-FU flux through the fungal nail plate ranged from 0.5 to
`15.5 µg/c111 2 /h and tended to increase with a decrease in nail
`
`30
`
`D
`
`D
`B
`'e B D
`D D
`'1:i ~ D
`D
`
`'ti
`
`D
`
`D
`
`• D
`
`D
`IDo D
`D Ro
`D
`of-,~~~~~~~~~~
`0
`200
`400
`600
`800
`I 000 1200
`h (µm)
`
`Fig. 4. Relationship between the 5-FU flux and heallhy nail plate thickness
`(µm) (11 = 78).
`
`of--'-'"T--~~~~~~~~~
`20
`JO
`0
`10
`40
`50
`
`l/h (cm")
`
`Fig. 5. Comparison between the healthy and the fungal nail plutc !luxes of
`5-FU. The closed circle(•) represents fungal nail plate (11 = 8), the open
`square (0) represents healthy nail plate (11 = 78); h: nail thickness (cm).
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1076 - Page 6 of 8
`
`

`
`Y. Kobayashi et al. I European Journal of Pharmaceutical Sciences 21 (2004) 471-477
`
`477
`
`In this investigation, very heavy fungal nail plates could
`not be used for two reasons. Firstly, the thickness of the nail
`plate cannot be detem1ined because it is ve1y uneven. Sec(cid:173)
`ondly, the uneven nail plate collapses in water. The flux of
`drug through a very heavy fungal nail plate may be higher
`than that through a healthy nail plate because of nail de(cid:173)
`struction by fungi.
`We found that the healthy nail permeability depends on
`the diffusivity of penetrant. Since an increase in nail thick(cid:173)
`ness leads to a decrease in healthy or fungal nail flux, the
`fungal nail pern1eability may also depend on the diffusivity
`of penetrant. As a result, we suggest that the pern1eability
`through healthy and fungal nail plates is not significantly
`different and the fungal nail pern1eability can be estimated
`from healthy nail penneability data.
`
`4. Conclusion
`
`In the present study, we investigated the in vitro nail
`permeation of several model drugs. Nail permeability was
`analyzed using a simple model based on the octanol/water
`partition coefficient and the 1nolecular weight of the drug.
`Although nail permeability was independent of the oc(cid:173)
`tanol/water partition coefficient of the penetrating drug, it
`n1arkedly decreased with increasing 111olecular weight. The
`dissociation of the drug led to a decrease in nail pern1eabil(cid:173)
`ity. It appears that the decrease in the permeability of ionic
`drugs is caused by a small increase (about 100) in the ap(cid:173)
`parent n1olecular weight due to ion hydration. It may be that
`the p·ermeabiiity Of the fungal- nail plate is approXhnately ·
`the same as the pern1eability of the healthy nail plate.
`
`Ackno\vledgements
`
`The authors wish to thank the volunteers at Josai Univer(cid:173)
`sity for supplying the healthy nail samples and the Saitama
`Medical Center (Saitama Medical School) and the Saiseikai
`Central I-Iospital for supplying the fungal nail san1ples.
`
`References
`
`Albeiy, W.J .. Greenwood, A.R., Kibble, R.F, 1967. Diffusion cocflicicnts
`of cal'boxyric acid. Trans. Faraday Soc. 63, 360--368.
`
`Flynn, G.L., Yalkowsky, S.H., Roseman, T.J., 1974. Mass transport phe(cid:173)
`nomena and models: theoretical concepts. J. Phann. Sci. 63, 479-
`510.
`Hatanaka, T., Shimoyarna, M., Sugibayashi, K., Morimoto. Y., 1993.
`Effect of vehicle on the skin penncability of drugs: polyethylene
`glycol-400-water and ethanol-water binaiy solvents. J. Controlled Re(cid:173)
`lease 23, 247-260.
`Jarrett, A., Spearman, R.l.C., 1966. The histochemistry of the human nail.
`Arch. Dermatol. 94, 652-657.
`Jillson, O.F, Piper, E.L., 1957. The role of the saprophytic fungi in the
`production of eczematous dcnnatitis. J. 11west. Dc111mtol. 28, 137-145.
`Kobayashi, Y., Nakamura, H., Sugibayashi, K., Morimoto, Y .. 1997. Esti(cid:173)
`mation of action site of1.-lactic acid·clhano!-isopropyl myristatc mixed
`system for its enhancing effect on the skin pcnneation of kctotifcn.
`Int. J. Pharm. 156, 153-162.
`Kobayashi, Y., Miyamoto, M., Sugibayashi, K., Morimoto, Y., 1998.
`Enhancing effect of N-acety!-t-cysteine or 2-mercaptocth:mol on the
`in vitro peimeation of 5-ftuorouracil or tolnaftalc through the human
`nail plate. Chem. Phann. Bull. 46, l 797- t 802.
`Kobayashi, Y., Miyamoto, M., Sugibayashi, K., Morimoto, Y., 1999. Drug
`penneation through the three layers of the human nail plate. J. Phann.
`Pharmcol. 51, 1-9.
`Mertin, D., Lippold, 8.C., 1997. In vitro permeubilit

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket